Mazzara Philip, General Counsel and Secretary, has demonstrated a pronounced selling bias in his trading activity involving Astera Labs (ALAB), according to SEC Form 4 filings. Over 49 reported transactions, he has sold shares worth approximately $9.51 million while purchasing only $6,817 in stock. The vast majority of his recent activity—24 sales since November 2025—has been concentrated in ALAB, with no buys recorded in the same period. His disposals have been executed in multiple tranches, often on the same day, such as the seven sales on March 2, 2026, which ranged from $24,196 to $377,342.72 in value. Earlier transactions followed a similar pattern, including five sales on February 17, 2026, totaling over $600,000, and eight sales on January 2, 2026, with individual transactions as large as $461,578.32.
The consistency and scale of Mazzara’s selling activity suggest a deliberate reduction in his ALAB holdings. While a single $0-value acquisition was noted on February 6, 2026—likely tied to equity awards—it did not offset the broader trend of divestment. His sales have been methodical, with no clustering around earnings reports or other market-moving events that might imply opportunistic timing. The absence of purchases alongside these disposals further underscores a one-directional approach. Given his role as General Counsel, the transactions were executed in compliance with disclosure requirements, but the sheer volume and continuity of sales distinguish his trading history within the company.
AI-assisted summary